With a new edition of a long-running awareness campaign, Genentech is drawing attention to the talents and passions that are ...

Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first ...

Following this week’s European Commission approval of Roche/Genentech’s Gazyvaro (obinutuzumab) for the treatment of lupus nephritis (LN), Spherix Global Insights’ latest RealTime Dynamix™: Lupus ...

Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.

Missing a trial goal in Alzheimer’s disease is a pretty common occurrence—see crenezumab, for the latest. But Genentech’s latest reported miss was something different. The Roche unit wanted to build a ...

– Updated overall survival (OS) results – a key secondary endpoint – reinforce the significant benefit of the Itovebi TM (inavolisib)-based regimen for patients with advanced PIK3CA-mutated, ...

Lunsumio in combination with lenalidomide may offer an effective treatment in relapsed or refractory follicular lymphoma ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

SOUTH SAN FRANCISCO, Calif. (KGO) -- Biotech drug manufacturer Genentech announced it is closing its production facility at South San Francisco. The company says it will also lay off about 265 ...

1976: Genentech founded by venture capitalist Robert Swanson and biochemist Herbert Boyer. 1977-79: Genentech develops genetic engineering techniques to create micro-organisms that can produce insulin ...

In this video from the American Academy of Ophthalmology meeting, Jennifer I. Lim, MD, MBA, discusses drugs in the pipeline that will provide more durability in retina.

Soon after federal prosecutors filed a bombshell indictment against former Genentech staffers for allegedly funneling trade secrets to Taiwanese biotech firm JHL, Genentech has filed its own legal ...